Drug Shortage Report for ARZERRA
| Report ID | 4093 |
| Drug Identification Number | 02381567 |
| Brand name | ARZERRA |
| Common or Proper name | Arzerra 1000MG VIALS |
| Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | Ofatumumab |
| Strength(s) | 1000MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 50ML X 1 |
| ATC code | L01XC |
| ATC description | OTHER ANTINEOPLASTIC AGENTS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2017-02-28 |
| Estimated end date | |
| Actual end date | 2018-09-26 |
| Shortage status | Resolved |
| Updated date | 2018-09-27 |
| Company comments | Product will be discontinued. Communication letter to follow. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
| Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2018-09-27 | English | Compare |
| v4 | 2018-09-26 | French | Compare |
| v3 | 2018-09-26 | English | Compare |
| v2 | 2017-03-23 | French | Compare |
| v1 | 2017-03-23 | English | Compare |
Showing 1 to 5 of 5